Distal oversizing is proposed as a contributing factor to distal stent graft-induced new entry tears, especially in managing the complications of aortic dissection. However, distal radial force can only be partially reduced by a tapered design or the use of distal restrictive stents or stent grafts. We report our early outcomes with a disease-specific, factory-modified Zenith Alpha thoracic stent graft (Cook Medical, Bloomington, Ind). Dissection-specific features include no proximal barbs; >20 cm in length and substantially tapered (custom-made, but usually by 10 mm); reduced radial force in the second and third distal stents and removal of the final stent, leaving 30 mm of unsupported graft; and an “endovascular elephant trunk.” A retrospective review was performed of all customized stent cases. Indications for use, technical difficulties, and incidence of further aortic sequelae were examined. Between February 2017 and July 2018, there were 14 patients who were treated (mean age, 55 years; range, 45-79 years; 4 female patients). Median follow-up was 15.5 months (range, 2-18 months). All intervention was performed for postdissection aneurysmal disease; nne patients had previous proximal aortic intervention, and four had an underlying connective tissue disorder. Three patients had scheduled further distal aortic treatment at the time of study intervention. Technical success was 100% and 30-day mortality 0%. No propagation of disease was noted on follow-up imaging. There was one late aneurysm-related death in a patient awaiting a fenestrated endovascular aneurysm repair. Use of this disease-specific stent graft design is not associated with any early technical issues or evidence of stent graft-induced new entry tears on short-term follow-up. Its impact on improving long-term outcome remains to be demonstrated.
Read full abstract